UK Short-Circuits OTC Device Pain Relief Claims For Diabetics, Arthritics
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Ad claims for Actegy's Revitive Circulation Booster device did not rely on clinical evidence that tested the actual product in the way consumers were advised to use it, UK advertising regulator says. Actegy maintained benefits from the device's TENS technology are similar to the effects of NMES technology used in studies it offered as evidence.
You may also be interested in...
Magnetic Device Menopause Symptom Treatment Claims Repelled In UK
UK Advertising Standards Authority says LadyCare medical device claims to relieve menopause symptoms through magnetic technology are not supported by consumer self-assessment surveys and need an adequately controlled experimental human study.
GSK Consumer Tries On Wearable Pain Relief With NeuroMetrix Deal
GSK Consumer purchases ex-US rights to pain relief device Quell from NeuroMetrix in a deal that includes co-development of transcutaneous electrical nerve stimulation products.
Industry Roundup: P&G Leadership, Unilever Sale, Ad Claims
Patterson Medical adds Performance Health; EarlySense targets consumer expansion; faster capsule filler available; and more news in brief.